DHC Acne Spot Therapy

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: DHC Acne Spot Therapy
Generic name: SULFUR
Manufacturer: DHC USA Incorporated
Product type: HUMAN OTC DRUG
SPL set ID: 84d49048-95cf-4f14-9698-c746237fec9d
SPL ID: 4ae85fb3-936c-45b4-95d9-b3206952cd94
Version: 4
Effective date: 2026-01-24
Source export date: 2026-10-12
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b939c18fdf51df171cf60ce5558819d08ac66bb16bb9991d48cbec91028d783e/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:38:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		DHC Acne Spot Therapy	openfda.brand_name
generic name		SULFUR	openfda.generic_name
manufacturer name		DHC USA Incorporated	openfda.manufacturer_name
ndc	package	63433-389-00	openfda.package_ndc
ndc	product	63433-389	openfda.product_ndc
ndc11	package	63433038900	derived:openfda.package_ndc
rxcui		199632	openfda.rxcui
spl id		4ae85fb3-936c-45b4-95d9-b3206952cd94	id
spl set id		84d49048-95cf-4f14-9698-c746237fec9d	set_id
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product skin irritation and dryness is more likely to occur if used with another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Avoid contact with eyes. If excessive skin irritation develops or increases, discontinue use and consult a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. Do not use on Broken skin Large areas of the skin When using this product Apply only to areas with acne

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.